Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Llama-Derived Antibody May Treat Retinitis Pigmentosa
A group of researchers from the University of California, Irvine, has made a significant discovery: an exceptional antibody that could pave the way for treating Retinitis Pigmentosa. This condition results in the deterioration of central vision, as well as night…
Micro Labs Launches World’s First Triple-Drug for Glaucoma
Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…
History of Ophthalmic Imaging | OBN
Early Retinal Imaging: The Beginnings of Ophthalmic Photography Early retinal imaging — The origins of (retinal) ophthalmic photography go back around 150 years when Drs Jackman and Webster, in the USA, published the first robust account of capturing images of…
Brazilian Study Finds Low Occurrence of Ocular Metastases
In a retrospective study conducted by Brazilian investigators, concerns about the occurrence of ocular metastases were addressed. Led by first author Matheus Senna Pereira Ogata, MD, from the Department of Ophthalmology and Visual Sciences at the Paulista Medical School, Federal…
Common Eye Conditions – Names of Eye Diseases List
In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…
Novo Nordisk Weight Loss Drugs Linked to Higher NAION Risk
A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…
Fenofibrate Reduces Diabetic Retinopathy Risk by 27%
In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…
Researchers Discover Novel Approach to Combat Vision Loss
A discovery in the treatment of age-related macular degeneration (AMD) has been unveiled by Cirrus Therapeutics, in collaboration with the University of Bristol and London’s Global University Institute of Ophthalmology. Published on the cover of the esteemed journal Science Translational…
Scientists Discover Protein to Regenerate Optic Nerve
Researchers at the University of Connecticut (UConn) have identified a potentially transformative factor for regenerating damaged optic nerves, which could ultimately prevent irreversible blindness. This discovery is published in the May 2024 issue of Experimental Neurology. The Impact of Optic…
Link Between Antioxidant Supplements and Late-Stage Dry AMD
In a significant development for the treatment of late-stage dry age-related macular degeneration (AMD), researchers at the National Institutes of Health (NIH) have identified that daily antioxidant supplements can potentially slow the progression of the disease, preserving central vision for…